Episode 135 - Preparing for a cell therapy IPO - Pete O'Heeron of FibroBiologics

May 25, 2022, 11:00 AM

Pete O’Heeron is the CEO, founder, and chairman of FiberBiologics, a Houston-based company that’s using fibroblast cell technology to treat a variety of chronic diseases. Pete shares how the company is gearing up to IPO, move into a new combined lab and manufacturing space, and launch two more clinical trials to further prove out the impact of fiber blast technology.